Current guidelines include recommendations on how to prescribe methylphenidate, but lack of recommendations regarding the long-term use of the drug.
Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available as of July 15, 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.
Researchers sought to determine risk factors for hospitalization in children with atopic dermatitis.
Self-experience could be valuable when clinically differentiating between schizotypal disorder and autism spectrum disorder.
Researchers found that a toddler diagnosed with autism spectrum disorder is unlikely to test within typical levels at age 3 years.
Subtle differences in cortical surface area are widespread in children with attention-deficit/hyperactivity disorder, confirming involvement of the frontal cortex.
Drugs modulating the vasopressin pathway explored as agents to modify social behaviors in autism.
Prevention programs may improve long-term outcomes in children and adolescents by addressing pre-existing vulnerabilities that increase the risk for exposure to bullying.
Existing developmental screening tools could be used to detect autism spectrum disorder more reliably and at younger ages.
A new tool aims to improve skills in adolescents and adults with autism spectrum disorder by providing virtual interactions with police officers.